AS Latvijas Juras medicinas centrs

    AS Latvijas Juras medicinas centrs

    MMUN:UOM
    - -
    EUR
    - -
    - -
    29.54P/E
    AS Latvijas Juras medicinas centrs
    MUN:UOM
    (Munich Stock Exchange)

    Recent

    price

    - -

    P/E

    ratio

    29.54

    div

    yld

    - -

    ROIC.AI

    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    2025
    TTM
    EUR
    5.98
    6.32
    6.74
    6.35
    6.84
    7.23
    7.75
    7.35
    8.34
    9.09
    8.8
    11.7
    12.13
    12.31
    12.74
    - -
    12.86
    Revenue per Share
    -0.19
    -0.15
    -0.12
    -0.4
    1.52
    -0.47
    0.14
    0.63
    -0.1
    0.21
    0.34
    1.1
    0.78
    -0.78
    0.23
    - -
    0.3
    Basic EPS, GAAP
    0.52
    -0.71
    -0.52
    0.12
    0.27
    0.13
    -0.7
    -0.16
    0.64
    0.28
    0.27
    -0.86
    0.58
    -0.71
    0.21
    - -
    -0.26
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    0.03
    0.4
    0.4
    0.1
    0.55
    0.07
    0.2
    0.1
    - -
    - -
    - -
    Dividend per Share
    3.77
    3.83
    3.91
    3.72
    5.19
    4.73
    4.99
    4.33
    3.83
    3.93
    3.7
    4.75
    5.34
    4.46
    4.41
    - -
    4.61
    Book Value per Share
    5.33
    5.22
    5.11
    4.74
    9.66
    8.89
    8.68
    7.27
    6.77
    6.88
    6.86
    7.93
    8.51
    7.75
    7.71
    - -
    7.91
    Tangible Book Value per Share
    1
    1
    1
    1
    1
    1
    1
    1
    1
    1
    1
    1
    1
    1
    1
    - -
    1
    Basic Weighted Avg Shares
    5
    5
    5
    5
    5
    6
    6
    6
    7
    7
    7
    9
    10
    10
    10
    10
    10
    Sales/Revenue/Turnover
    -3.48
    -2.06
    -1.48
    -6.41
    18.77
    -3.51
    -0.27
    0.45
    -3.26
    0.66
    2.1
    8.19
    5.23
    -1.81
    0.71
    1.1
    1.1
    Operating Margin (%)
    1
    1
    1
    1
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    1
    1
    - -
    Depreciation Expense
    - -
    - -
    - -
    - -
    1
    - -
    - -
    1
    - -
    - -
    - -
    1
    1
    -1
    - -
    - -
    - -
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    3.06
    - -
    0.57
    0.39
    0.07
    0.1
    - -
    0.33
    6.69
    6.69
    Effective Tax Rate (%)
    -3.15
    -2.33
    -1.8
    -6.28
    22.22
    -6.48
    1.81
    8.62
    -1.2
    2.26
    3.86
    9.4
    6.45
    -6.34
    1.82
    2.34
    2.34
    Profit Margin (%)
    2
    1
    1
    1
    1
    1
    2
    1
    2
    2
    1
    1
    1
    -1
    -1
    - -
    - -
    Working Capital
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    LT Debt
    4
    4
    4
    4
    8
    7
    7
    6
    5
    6
    6
    6
    7
    6
    6
    6
    6
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    12.54
    - -
    5.29
    8.93
    25.95
    15.5
    - -
    5.22
    6.68
    6.68
    Return on Capital (%)
    -5.01
    -3.88
    -3.13
    -10.46
    34.17
    -9.45
    2.84
    13.77
    -2.45
    5.29
    8.93
    25.95
    15.5
    -15.94
    5.22
    6.68
    6.68
    Return on Common Equity (%)

    Capital Structure

    EUR

    •

    in mil. unless spec.
    Jun'25
    Sep'25
    Dec'25
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    1
    1
    1
    Market Capitalization
    5
    5
    7

    Working Capital

    EUR

    •

    in mil. unless spec.
    Jun'25
    Sep'25
    Dec'25
    Total Current Assets
    2
    2
    2
    Cash, Cash Equivalents & STI
    1
    1
    1
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    2
    2
    2
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    EUR

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    -0.86%
    3.09%
    2.61%
    Free Cash Flow
    -243.29%
    -232.03%
    -223.25%
    Net Income, GAAP
    -22.61%
    -21.28%
    30.15%
    Sales/Revenue/Turnover
    6.33%
    8.36%
    0.97%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    2
    2
    3
    3
    10
    2024
    3
    2
    3
    3
    10
    2025
    3
    3
    3
    3
    10

    Quarterly Earnings Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -0.17
    - -
    - -
    - -
    -0.78
    2024
    0.11
    - -
    - -
    - -
    0.23
    2025
    0.04
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    0.1
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business